Moderna, Merck say vaccine improved survival in patients with deadly skin cancer

Nearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their cancer returning at the 2½-year mark.

View full article

...

Latest News

Surprise primary upset leaves Puerto Rico governor out of re-election bid

1 week ago

Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits

1 week ago

Modi's party set to lose its majority in shock India election result

1 week ago

India's Narendra Modi declares victory despite election blow

1 week ago

Here's how 'spaving' could hurt your finances

1 week ago